SEC 13F Intelligence

King Luther Capital Management Corp / ABT

King Luther Capital Management Corp’s Abbott Laboratories Position

Does King Luther Capital Management Corp own Abbott Laboratories (ABT)? Yes — 1.31M shares worth $134M (+0.58% of its 13F portfolio) as of Q1 2026, down from 1.46M shares the prior filed quarter.

Position Value
$134M
Q1 2026
Shares
1.31M
% of Portfolio
+0.58%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $155MQ4 ’18Q1 ’19: $173MQ2 ’19: $184MQ3 ’19: $185MQ4 ’19: $195MQ4 ’19Q1 ’20: $178MQ2 ’20: $204MQ3 ’20: $241MQ4 ’20: $243MQ4 ’20Q1 ’21: $263MQ2 ’21: $249MQ3 ’21: $255MQ4 ’21: $299MQ4 ’21Q1 ’22: $250MQ2 ’22: $226MQ3 ’22: $201MQ4 ’22: $226MQ4 ’22Q1 ’23: $205MQ2 ’23: $225MQ3 ’23: $199MQ4 ’23: $218MQ4 ’23Q1 ’24: $184MQ2 ’24: $161MQ3 ’24: $167MQ4 ’24: $162MQ4 ’24Q1 ’25: $188MQ2 ’25: $194MQ3 ’25: $192MQ4 ’25: $183MQ4 ’25Q1 ’26: $134Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.31M$134M+0.58%
Q4 20251.46M$183M+0.75%
Q3 20251.44M$192M+0.79%
Q2 20251.43M$194M+0.84%
Q1 20251.42M$188M+0.87%
Q4 20241.43M$162M+0.70%
Q3 20241.46M$167M+0.71%
Q2 20241.55M$161M+0.73%
Q1 20241.62M$184M+0.83%
Q4 20231.98M$218M+1.05%
Q3 20232.06M$199M+1.04%
Q2 20232.06M$225M+1.12%
Q1 20232.03M$205M+1.08%
Q4 20222.06M$226M+1.24%
Q3 20222.07M$201M+1.20%
Q2 20222.08M$226M+1.27%
Q1 20222.11M$250M+1.22%
Q4 20212.12M$299M+1.35%
Q3 20212.16M$255M+1.25%
Q2 20212.15M$249M+1.22%
Q1 20212.20M$263M+1.41%
Q4 20202.22M$243M+1.37%
Q3 20202.22M$241M+1.52%
Q2 20202.23M$204M+1.41%
Q1 20202.26M$178M+1.55%
Q4 20192.24M$195M+1.30%
Q3 20192.21M$185M+1.35%
Q2 20192.19M$184M+1.34%
Q1 20192.16M$173M+1.32%
Q4 20182.14M$155M+1.38%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See King Luther Capital Management Corp’s full portfolio or all institutional holders of ABT.